Andreas Menke
www.ppp.ukw.de
0000-0002-1498-1992
University Hospital Wuerzburg
47 papers found
Refreshing results…
Association of Genetic Variants in the Neurotrophic Receptor–Encoding GeneNTRK2and a Lifetime History of Suicide Attempts in Depressed Patients
Gene Expression Studies in Major Depression
Genome-Wide Gene-Expression Profiles Following Glucocorticoid Stimulation Associated with Major Depression
Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response
Somatisation in major depression, genetic association and clinical features
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment
Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11–15 October 2008:
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature project
Genome-wide association study of antidepressant induced treatment emergent suicidal ideation (TESI)
Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression
Polymorphisms in the drug transporter gene ABCB1 in treatment resistant depression: clinical practice
Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression.
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors
Subset of Genetic Markers Associated with Antidepressant Treatment Emergent Suicidal Ideation
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients
P.2.a.007 Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression
Missing publications? Search for publications with a matching author name.